ArticleInflammatory bowel diseases2025

Vedolizumab Does Not Affect Antibody Secreting Cell Recruitment to the Lactating Mammary Gland of Mothers With Inflammatory Bowel Disease.

Josef Urrete et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.